跳至主要内容
临床试验/NCT02057198
NCT02057198已完成4 期

Exploratory Study of Impact of Oral Metronidazole, Vancomycin and Fidaxomicin on the Extent and Quantity of Host Carriage and Environmental Contamination With C. Difficile

Duke University1 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2014年6月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
33
试验地点
1
主要终点
Change in Total Median Total Colony Forming Units (CFU) of C. Difficile Identified in the Hospital Room Environment for Each Antibiotic Treatment Group.

研究概览

简要总结

The overall aim is to characterize and to compare the extent and quantity of C. difficile stool shedding, perianal colonization and environmental contamination in patients who received oral fidaxomicin, oral metronidazole, or oral vancomycin. This is a prospective, randomized, microbiologic and molecular, study of environmental contamination from patients with proven C. difficile associated diarrhea (CDAD).

详细描述

Background and Significance:

C. difficile has emerged as one of the most important pathogens that threaten the health and quality of life for many populations. Data from different studies clearly indicate that shedding of viable spores and subsequent contamination of environmental surfaces play an important role in the transmission of C. difficile. We aim to perform an analysis of the impact of different oral antibiotic therapy on microbiologic kinetics in patients with C. difficile diarrhea, such as: shedding, colonization and environmental contamination. We believe data from this study can inform whether drug therapies may be used to interrupt disease transmission and to improve the infection control of C. difficile.

Purpose of the Study:

The purposes of this study are to 1) determine the impact of oral fidaxomicin, oral metronidazole and oral vancomycin on the baseline and the temporal variation of C. difficile isolated from specific body sites of a patient with microbiology-proven CDAD and 2) determine the impact of oral fidaxomicin, oral metronidazole and oral vancomycin on the baseline and the temporal variation of C. difficile isolated from targeted surfaces in a hospital room. , More specifically, we will establish the extent and quantity of C. difficile shedding, colonization and environmental contamination in patients who received oral fidaxomicin, oral metronidazole, or vancomycin and the duration that stool remains positive for C. difficile.

This study will prospectively study the role of the environment in Healthcare Associated Infections (HAIs) in the modern healthcare setting and will specifically address many limitations of previous studies. The study will use modern diagnostic and molecular methods to describe the microbiologic characteristics and concordance of cultures from the environment and from patient, describe temporal variation and relationship in the microbiologic profiles of cultures obtained from the environment and from the patient, assess confounders such as hand hygiene and quality of cleaning, and provide longitudinal follow up for subsequent outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adult patients with microbiology-proven CDAD
  • provides informed consent
  • eligible to receive oral antibiotic therapy

排除标准

  • prisoners
  • pregnant women
  • children <18 years
  • patients who have contra-indications for perianal swabs, those who has medical conditions that would invalidate the results of the swabs
  • patients requiring intravenous therapy for treatment of CDAD
  • patients who do not consent and those who withdraw consent

研究组 & 干预措施

Fidaxomicin

Active Comparator

200 mg. 2 times a day for 10 days

干预措施: Fidaxomicin (Drug)

Metronidazole

Active Comparator

500 mg.orally 3 times daily for 10 days

干预措施: Metronidazole (Drug)

Vancomycin

Active Comparator

125 mg. orally 4 times a day for 10 days

干预措施: Vancomycin (Drug)

结局指标

主要结局

Change in Total Median Total Colony Forming Units (CFU) of C. Difficile Identified in the Hospital Room Environment for Each Antibiotic Treatment Group.

时间窗: Days 0, 3, 7 and 14.

Rodac plates were used to take environmental samples from 5 different sites within each patient's hospital room (bedrail, overbed table, sink, toilet seat, bathroom floor). Each Rodac plate samples a surface area of \~25 cm2. 5 replicates were taken for each site and repeated on days 0, 3, 7, and 14. Median total colony counts are reported for each treatment group. Data from the specified time points were combined to construct a decay slope, representing the reduction in log(CFUs)/day for each treatment group. We compared the slope (rate of change) between treatment groups using mixed effects models.

次要结局

  • Molecular Relatedness of Isolates(Days 0-14)
  • Count of Stool Specimens From Patients That Are Positive for C. Difficile(Days 0, 3, 7, 14)
  • Total Environmental Contamination According to Antibiotic Treatment Group(Days 0, 3, 7, and 14)
  • C. Difficile Shedding in Stool Over Time(Days 0, 3, 7, 14)
  • Percentage of Stool Specimens From Patients That Are Positive for C. Difficile(Days 0, 3, 7, 14)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验